Dr. Fraulino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
263 Farmington Ave
Farmington, CT 06030
Education & Training
National Jewish HospitalMycobacterial Disease, 2021 - 2022
University of ColoradoFellowship, Infectious Disease, 2020 - 2022
University of ConnecticutResidency, Internal Medicine, 2017 - 2020
University of New England College of Osteopathic MedicineClass of 2017
Certifications & Licensure
CT State License 2017 - 2025
CO State License 2021 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension Start of enrollment: 2024 Jun 01
Publications & Presentations
PubMed
- 1 citationsCurrent challenges in pulmonary nontuberculous mycobacterial infection: a case series with literature review.Mark L Metersky, David Fraulino, Lea Monday, Teena Chopra
Postgraduate Medicine. 2024-09-01 - 2 citationsFive-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.Timothy R Aksamit, Nicholas Locantore, Doreen Addrizzo-Harris, Juzar Ali, Alan Barker
American Journal of Respiratory and Critical Care Medicine. 2024-07-01 - 4 citationsChasing the Ghost: Hyperinflammation Does Not Cause Sepsis.Leland Shapiro, Sias Scherger, Carlos Franco-Paredes, Amal A Gharamti, David Fraulino
Frontiers in Pharmacology. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
